The pharmacology of lysergic acid diethylamide: a review. - Test2 - elhamkhani - TriplyDB

The pharmacology of lysergic acid diethylamide: a review.

The pharmacology of lysergic acid diethylamide: a review.

http://www.wikidata.org/entity/Q22242295

about

Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study Visual trails: do the doors of perception open periodically?Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials Lysergic acid diethylamide: a drug of 'use'?Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro Psychedelics LSD enhances the emotional response to music.LSD-induced entropic brain activity predicts subsequent personality change.Modern Clinical Research on LSD.Alterations of consciousness and mystical-type experiences after acute LSD in humans.Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects.A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects.Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases.The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series.Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample."My friend said it was good LSD": a suicide attempt following analytically confirmed 25I-NBOMe ingestion.Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans.Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)Clinical applications of hallucinogens: A review.Drug Abuse and Psychosis: New Insights into Drug-induced Psychosis Ergot alkaloids produced by endophytic fungi of the genus Epichloë.Evolutionary constraints on visual cortex architecture from the dynamics of hallucinations.Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality Sensory dynamics of visual hallucinations in the normal population.Forensic aspects of drug-induced violence.Emerging treatment for chronic migraine and refractory chronic migraine.Alternative drugs of abuse.Licit and illicit drug use in cluster headache.Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation.Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.Ergoline-derived inverse agonists of the human h3 receptor for the treatment of narcolepsy.

P2860

Q21134103-2C6BFDB4-8DC2-474E-B359-FCD53A0F51A7 Q21145773-1C70D7B6-38E7-48C5-9322-B8A921604AD4 Q22241828-B564ED1D-C06F-4303-8C1F-6AEAA0AF298D Q26746133-A050FA69-EF01-4F12-9CB4-81A71402C5EE Q26746137-16A447A4-3213-47D3-9B86-987F2B21434E Q26799997-2012A440-5AF2-47CD-92F7-3EE6CFE0895C Q26865329-55D03B17-A30B-4655-9F8D-6D33E1E2F540 Q28067851-D78D2E58-F187-462D-89FF-3F3530992435 Q28307141-C8653B7A-8708-41C6-8DC9-976ABC971652 Q30359998-2B7D503A-DDBF-4645-8059-C5E6BCCC4C2B Q30377709-274D384F-28E2-45B6-97F3-98556D9DB863 Q30387757-EDB57132-F4E1-42CA-B92E-11280B2B4BF4 Q30401421-B7057487-A719-4403-95DF-ACF2E551F791 Q30847957-86412AA4-03B3-468E-89B1-790EF7559CCB Q33635662-052AC713-60AC-455A-BEE2-A73F6B653DF9 Q33843524-73796680-1606-430B-99C5-2C424D02AF21 Q33863459-A6793E80-3E81-42E5-905A-D57DB8701409 Q34131481-0D2F10EE-267B-4F87-9B2E-8AB6383535FC Q34165511-53138BF8-FBAD-499C-9500-13B7448A8D95 Q34406732-287BB3F0-62CE-45F6-8D28-6C586F9D72ED Q34453002-632D0301-53CE-4C5B-8A16-B73E78BA8070 Q34482174-2B63A1E1-7F04-43EA-8CB3-05B07960599E Q34497649-AEB83FA7-4EA9-41B5-95C1-A9725B67670B Q34535259-50ECD3A2-5582-4039-A0F6-F224942AA95D Q34680922-A11C37EC-5A6E-42F7-A284-17C9E1EC86D4 Q35232716-2D2EBAE4-D53A-4CDC-87EC-44D7752E239C Q35673851-2A740C9A-7719-4002-B2FD-6C0B6AF56BBE Q35737157-E9F33873-B770-4CBC-85FC-A21486BA5F44 Q36574422-702E8650-59EA-4688-880C-02FC10812DE3 Q37262799-B7CF80AA-6F5E-4AC3-BE10-6F1C8366D6E1 Q37329064-334FABC8-006F-4AE7-ABC3-6629D0573CC8 Q37973043-33E7CD34-CEAA-4801-8067-434E0A711F5E Q38031982-39C0A3BF-3B1D-498C-BC24-8BDF025DD307 Q38103475-1E77FEE8-EAEB-4C5C-AFD9-FC83BDC55269 Q38203237-62C61B9C-F212-49A6-88E6-3ABC5747FCA9 Q38351502-ABD5D049-53B4-469E-964A-D6613E5942A6 Q38733778-DB25D703-5961-42BF-B0F1-88459164A958 Q38761743-A0B886D8-35E4-4280-A791-F524073BD931 Q38961114-12444BDB-968A-4786-93DE-AFE67DD71ADD Q38992826-4BFB65E3-5E4C-4A7D-9E65-17B1A8FB6AEA

P2860

The pharmacology of lysergic acid diethylamide: a review.

http://www.wikidata.org/entity/Q22242295

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

The Pharmacology of Lysergic Acid Diethylamide: A Review

@ast

The Pharmacology of Lysergic Acid Diethylamide: A Review

@nl

The pharmacology of lysergic acid diethylamide: a review.

@en

type

label

The Pharmacology of Lysergic Acid Diethylamide: A Review

@ast

The Pharmacology of Lysergic Acid Diethylamide: A Review

@nl

The pharmacology of lysergic acid diethylamide: a review.

@en

altLabel

The pharmacology of lysergic acid diethylamide: a review

@en

prefLabel

The Pharmacology of Lysergic Acid Diethylamide: A Review

@ast

The Pharmacology of Lysergic Acid Diethylamide: A Review

@nl

The pharmacology of lysergic acid diethylamide: a review.

@en

P1433

Q22242295-A5C5E620-C291-4816-861E-93777C93C7D5

P1476

Q22242295-892E18C0-E77C-45C5-8A34-C8D79B216ACF

P2093

Q22242295-00452A31-2011-4F69-A3F1-53829CA680EB

Q22242295-45E96042-8DB7-4373-8988-7F8EECAF17BF

Q22242295-C9A41A26-E8FA-4E79-AF53-D0F95F3B1293

Q22242295-CF19EFB8-2B76-4C2B-9E7F-D40D688A65CC

Q22242295-DD0F2CDD-0671-4425-AC39-EDFBA2DB180C

P2860

Q22242295-08713075-C2C4-449C-B1A8-D93F91C085D3

Q22242295-14A7FA6B-01AE-4DEA-B304-F72A8AFAA147

Q22242295-3815AAFE-56D8-41B6-B8F0-77836137E9DE

Q22242295-3C5F64F3-4E60-4B49-A975-EBC9A4F12298

Q22242295-4D7847FF-AF94-453C-AF5E-373E41FAB324

Q22242295-5B713928-7531-4237-82FA-D1E036A44A0A

Q22242295-975EA97A-43D0-4E4E-8785-C09B8006FDEB

Q22242295-A036AAB0-1E20-4A29-99CF-DA5ED7EC7828

Q22242295-AB9FE6B3-DA63-45A8-BD23-8FF89E47C38E

Q22242295-BE3F36AF-09B0-4781-BC30-BE3A5A101AE9

P304

Q22242295-61327A67-8103-4F24-9343-CEFB9810A427

P31

Q22242295-CD58B328-5413-4868-BD9F-5D1922D4E475

P3181

Q22242295-6CD0D526-696D-43EA-996F-130667943BCA

P356

Q22242295-2430D8D9-C612-40D0-BD2C-FC1D3ED800BA

P407

Q22242295-15698FF0-52F5-47A0-B348-004359EAF357

P433

Q22242295-6C70B741-4995-4C7E-B32D-EF43DA2E1D1C

P478

Q22242295-C382BA89-F765-4B09-ACDF-F4073A2273F9

P577

Q22242295-525224C1-4EC4-4F5A-95FE-DBD08CBE2C51

P5875

Q22242295-F579FA28-ED1B-4676-B63C-08F406FC33B5

P698

Q22242295-8BD9C760-BB99-458E-9937-A6C121771C0E

P921

Q22242295-3CECBE50-6297-4397-A50C-EF3F4A352532

P932

Q22242295-4CB0C2E7-31D9-438C-B795-357F686CBC70

P3181

P356

J.1755-5949.2008.00059.X

P1433

CNS Neuroscience & Therapeutics

P1476

The pharmacology of lysergic acid diethylamide: a review.

@en

P2093

Annelie Hintzen

http://www.w3.org/2001/XMLSchema#string

Dirk O Stichtenoth

http://www.w3.org/2001/XMLSchema#string

Hinderk M Emrich

http://www.w3.org/2001/XMLSchema#string

John H Halpern

http://www.w3.org/2001/XMLSchema#string

Torsten Passie

http://www.w3.org/2001/XMLSchema#string

P2860

Measurement of Lysergic Acid Diethylamide (LSD) in Human Plasma by Gas Chromatography/Negative Ion Chemical Ionization Mass Spectrometry

Psychopathology and Psychophysiology of Minimal LSD-25 Dosage

Long Lasting Effects of LSD on Normals

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.

PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.

D-LYSERGIC ACID DIETHYLAMIDE (LSD): A REVIEW OF ITS PRESENT STATUS.

The clinical utility of pharmacological agents that act at serotonin receptors.

Adrenal cortical responses to stress in normal men and in those with personality disorders; analysis of the pituitary-adrenal mechanism in man.

LSD revisited. A ten-year follow-up of medical LSD use.

A mathematical model for the pharmacokinetics of LSD effect.

P304

295-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3046775

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1755-5949.2008.00059.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23553521

http://www.w3.org/2001/XMLSchema#string

P698

19040555

http://www.w3.org/2001/XMLSchema#string

P921

P932

6494066

http://www.w3.org/2001/XMLSchema#string